AKT1 and thyroid cancer: Another study has shown that oleuropein and its peracetylated derivative inhibit cell proliferation in two thyroid cancer cell lines, TPC-1 and BCPAP, by triggering MAP kinase and PI3K-AKT signaling pathways and exerting antioxidant effects [57].